<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460295</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Drivers of COVID-19 Vaccination among Eligible Adults in Abuja, Nigeria: A Mixed-Methods Study Using the WHO Behavioral and Social Drivers of Vaccination Framework.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1128</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101128</ELocationID><Abstract><AbstractText>Despite the availability of COVID-19 vaccines, Nigeria still faces significant COVID-19 vaccine hesitancy, with only 60.7% of the eligible population fully vaccinated as of 20 March 2023. Our study, part of a community-based effort to improve knowledge and uptake of the COVID-19 vaccine in the Gwagwalada Area Council of Abuja, the Federal Capital Territory (FCT) of Nigeria, utilized the WHO's Behavioral and Social Drivers (BeSDs)-of-vaccination framework to examine the drivers of COVID-19 vaccination among eligible adults. This was a mixed-method study with focus group discussions (FGDs) and in-depth interviews (IDIs) involving 40 purposively sampled participants. We triangulate qualitative findings with data from a household survey of 1512 eligible adults identified using a two-stage systematic cluster sampling approach. All data were collected from the 1-18 November 2022. The household survey showed 46% COVID-19 vaccine uptake, with Pearson chi-square and Fisher's exact test showing significant associations between vaccine uptake and gender, religion, and education. Multivariate logistic regression showed that confidence in vaccine safety, knowing vaccination sites and family/friends' endorsement of COVID-19 vaccination were the strongest items associated with vaccine uptake in the thinking-and-feeling, practical-issue, and social-process domains, respectively. Multiple items measuring these domains aligned with BeSD priority question, demonstrating the robustness of the pared-down framework. Qualitative data corroborated these findings. To address vaccine hesitancy and increase uptake, community-driven approaches to improve trust in vaccine safety and benefits and promote positive vaccination norms are needed. In addition, service delivery strategies to make vaccination services easily accessible and identifiable should be developed and tailored to community needs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wonodi</LastName><ForeName>Chizoba B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health Baltimore, Baltimore, MD 21231, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Women Advocates for Vaccine Access, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okpe</LastName><ForeName>Ikechukwu A</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0009-0004-3944-049X</Identifier><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angioha</LastName><ForeName>Pius U</ForeName><Initials>PU</Initials><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebong</LastName><ForeName>Affiong S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Women Advocates for Vaccine Access, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adegbola</LastName><ForeName>Janet B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdulraheem</LastName><ForeName>Abdulrasheed A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezeanya</LastName><ForeName>Nwamaka</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0008-8782-0365</Identifier><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adetola</LastName><ForeName>Adewumi A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arogundade</LastName><ForeName>Oluwatosin I</ForeName><Initials>OI</Initials><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadley</LastName><ForeName>Goodness I</ForeName><Initials>GI</Initials><AffiliationInfo><Affiliation>Women Advocates for Vaccine Access, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olisa</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Direct Consulting and Logistics, Maitama, Abuja 904101, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>050171-00</GrantID><Agency>Sabin Vaccine Institute</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BeSD framework</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">adult vaccination</Keyword><Keyword MajorTopicYN="N">socio-behavioral drivers</Keyword></KeywordList><CoiStatement>Authors Ikechukwu A. Okpe, Pius U. Angioha, Janet B. Adegbola, Abdulrasheed A. Abdulraheem, Nwamaka Ezeanya, Adewumi A. Adetola, Oluwatosin I. Arogundade and Joseph A. Olisa were employed by the company Direct Consulting and Logistics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460295</ArticleId><ArticleId IdType="pmc">PMC11512426</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101128</ArticleId><ArticleId IdType="pii">vaccines12101128</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sato R. COVID-19 Vaccine Hesitancy and Trust in Government in Nigeria. Vaccines. 2022;10:1008. doi: 10.3390/vaccines10071008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071008</ArticleId><ArticleId IdType="pmc">PMC9317906</ArticleId><ArticleId IdType="pubmed">35891171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekwebelem O.C., Onyeaka H., Yunusa I., Miri T., Onwuneme Y.M., Eunice A.T., Anyogu A., Obi B., Carol N.A. Do we trust the government? Attributes of COVID-19 vaccine hesitancy and acceptance in Nigeria. AIMS Med. Sci. 2022;9:268–282. doi: 10.3934/medsci.2022010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/medsci.2022010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chutiyami M., Bello U.M., Salihu D., Kolo M.A., Alsharari A.F., Sabo H., Bukar M., Shehu U., Adamu H., Alkali H.I., et al. Subjective Reasons for COVID-19 Vaccine Hesitancy and Sociodemographic Predictors of Vaccination in Nigeria: An Online Survey. COVID. 2022;2:1329–1340. doi: 10.3390/covid2100097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid2100097</ArticleId></ArticleIdList></Reference><Reference><Citation>Anorue L.I., Ugwu A., Ugboaja S.U., Nwabunze U.O., Ugwulor-Onyinyechi C.C., Njoku C.E. Communicating COVID-19 Vaccine Safety: Knowledge and Attitude Among Residents of Southeast, Nigeria. Inf. Drug Res. 2021;14:3785–3794. doi: 10.2147/IDR.S329183.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S329183</ArticleId><ArticleId IdType="pmc">PMC8453440</ArticleId><ArticleId IdType="pubmed">34557003</ArticleId></ArticleIdList></Reference><Reference><Citation>Shragai T., Adegoke O.J., Ikwe H., Sorungbe T., Haruna A., Williams I., Okonkwo R., Onu K., Asekun A., Gberikon M., et al. Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunization (AEFI) data in Nigeria. BMJ Glob. Health. 2023;8:e011006. doi: 10.1136/bmjgh-2022-011006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2022-011006</ArticleId><ArticleId IdType="pmc">PMC9852739</ArticleId><ArticleId IdType="pubmed">36650016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wonodi C., Obi-Jeff C., Adewumi F., Keluo-Udeke S.C., Gur-Arie R., Krubiner C., Faden R. Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications. Vaccine. 2022;40:2114–2121. doi: 10.1016/j.vaccine.2022.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.02.005</ArticleId><ArticleId IdType="pmc">PMC8830779</ArticleId><ArticleId IdType="pubmed">35153088</ArticleId></ArticleIdList></Reference><Reference><Citation>Alagarsamy S., Mehrolia S., Pushparaj U., Jeevananda S. Explaining the intention to uptake COVID-19 vaccination using the behavioral and social drivers of vaccination (BeSD) model. Vaccine X. 2022;10:100140. doi: 10.1016/j.jvacx.2021.100140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2021.100140</ArticleId><ArticleId IdType="pmc">PMC8730788</ArticleId><ArticleId IdType="pubmed">35013727</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   World Health Organization; 2022.  [(accessed on 3 April 2023)]. Behavioural and Social Drivers of Vaccination: Tools and Practical Guidance for Achieving High Uptake. Available online:  https://apps.who.int/iris/handle/10665/354459.</Citation></Reference><Reference><Citation>Masters N.B., Zhou T., Meng L., Lu P.J., Kriss J.L., Black C., Omari A., Boone K., Weiss D., Carter R.J., et al. Geographic Heterogeneity in Behavioral and Social Drivers of COVID-19 Vaccination. Am. J. Prev. Med. 2022;63:883–893. doi: 10.1016/j.amepre.2022.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2022.06.016</ArticleId><ArticleId IdType="pmc">PMC9296705</ArticleId><ArticleId IdType="pubmed">36404022</ArticleId></ArticleIdList></Reference><Reference><Citation>Moucheraud C., Phiri K., Whitehead H.S., Songo J., Lungu E., Chikuse E., Phiri S., Van Oosterhout J.J., Hoffman R.M. Uptake of the COVID-19 vaccine among healthcare workers in Malawi. Int. Health. 2022;15:77–84. doi: 10.1093/inthealth/ihac007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/inthealth/ihac007</ArticleId><ArticleId IdType="pmc">PMC9808523</ArticleId><ArticleId IdType="pubmed">35294960</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S., Gudi N., Nambiar D., Dumka N., Ahmed T., Sonawane I.R., Kotwal A. A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries. J. Glob. Health. 2021;11:05027. doi: 10.7189/jogh.11.05027.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.11.05027</ArticleId><ArticleId IdType="pmc">PMC8645216</ArticleId><ArticleId IdType="pubmed">34912550</ArticleId></ArticleIdList></Reference><Reference><Citation>Rikard-Bell M., Elhindi J., Lam J., Seeho S., Black K., Melov S., Jenkins G., McNab J., Wiley K., Pasupathy D. COVID-19 vaccine acceptance among pregnant women and the reasons for hesitancy: A multi-centre cross-sectional survey. Aust. N. Z. J. Obstet. Gynaecol. 2022;63:335–343. doi: 10.1111/ajo.13622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajo.13622</ArticleId><ArticleId IdType="pmc">PMC9874455</ArticleId><ArticleId IdType="pubmed">36259472</ArticleId></ArticleIdList></Reference><Reference><Citation>NOI Polls  COVID-19 Poll Result. 2020.  [(accessed on 2 September 2021)].  Available online:  https://www.noi-polls.com/post/covid-19-poll-result.</Citation></Reference><Reference><Citation>Hoshaw-Woodard, Stacy &amp; World Health Organization  . World Health Organization; 2021.  [(accessed on 2 September 2024)]. Description and Comparison of the Methods of Cluster Sampling and Lot Quality Assurance Sampling to Assess Immunization Coverage/Written by Stacy Hoshaw-Woodward. Available online:  https://iris.who.int/handle/10665/66867.</Citation></Reference><Reference><Citation>ODK—Collect Data Anywhere.  [(accessed on 24 August 2024)].  Available online:  https://getodk.org/</Citation></Reference><Reference><Citation>Rozek L.S., Jones P., Menon A., Hicken A., Apsley S., King E.J. Understanding Vaccine Hesitancy in the Context of COVID-19: The Role of Trust and Confidence in a Seventeen-Country Survey. Int. J. Public Health. 2021;66:636255. doi: 10.3389/ijph.2021.636255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2021.636255</ArticleId><ArticleId IdType="pmc">PMC8565283</ArticleId><ArticleId IdType="pubmed">34744589</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibbels N.J., Dosso A., Fordham C., Benie W., Brou J.A., Kamara D., Hendrickson Z.M., Naugle D. “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults. Vaccine. 2022;40:2028–2035. doi: 10.1016/j.vaccine.2022.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.02.032</ArticleId><ArticleId IdType="pmc">PMC8831134</ArticleId><ArticleId IdType="pubmed">35181151</ArticleId></ArticleIdList></Reference><Reference><Citation>Milkman K.L., Patel M.S., Gandhi L., Graci H.N., Gromet D.M., Ho H., Kay J.S., Lee T.W., Akinola M., Beshears J., et al. A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor’s appointment. Proc. Natl. Acad. Sci. USA. 2021;118:e2101165118. doi: 10.1073/pnas.2101165118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101165118</ArticleId><ArticleId IdType="pmc">PMC8157982</ArticleId><ArticleId IdType="pubmed">33926993</ArticleId></ArticleIdList></Reference><Reference><Citation>Oku A., Oyo-Ita A., Glenton C., Fretheim A., Ames H., Muloliwa A., Kaufman J., Hill S., Cliff J., Cartier Y., et al. Communication strategies to promote the uptake of childhood vaccination in Nigeria: A systematic map. Glob. Health Action. 2016;9:30337. doi: 10.3402/gha.v9.30337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/gha.v9.30337</ArticleId><ArticleId IdType="pmc">PMC4754015</ArticleId><ArticleId IdType="pubmed">26880154</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos H.C., Goren A., Chabris C.F., Meyer M.N. Effect of Targeted Behavioral Science Messages on COVID-19 Vaccination Registration Among Employees of a Large Health System. JAMA Netw. Open. 2021;4:e2118702. doi: 10.1001/jamanetworkopen.2021.18702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.18702</ArticleId><ArticleId IdType="pmc">PMC8319759</ArticleId><ArticleId IdType="pubmed">34319359</ArticleId></ArticleIdList></Reference><Reference><Citation>Antwi-Berko D., Bakuri A.Z., Otabil K.B., Kwarteng A. Determinants and Variations of COVID-19 Vaccine Uptake and Responses Among Minority Ethnic Groups in Amsterdam, the Netherlands. Front. Public Health. 2022;10:761987. doi: 10.3389/fpubh.2022.761987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.761987</ArticleId><ArticleId IdType="pmc">PMC8891150</ArticleId><ArticleId IdType="pubmed">35252081</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu B., Zhang Y., Chen L.Q., Yu L., Li L., Wang Q. The influence of social network on COVID-19 vaccine hesitancy among healthcare workers: A cross-sectional survey in Chongqing, China. Hum. Vaccines Immunother. 2022;17:5048–5062. doi: 10.1080/21645515.2021.2004837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.2004837</ArticleId><ArticleId IdType="pmc">PMC8903998</ArticleId><ArticleId IdType="pubmed">34982646</ArticleId></ArticleIdList></Reference><Reference><Citation>Edge R., Heath J., Rowlingson B., Keegan T., Isba R. Seasonal Influenza Vaccination amongst Medical Students: A Social Network Analysis Based on a Cross-Sectional Study. PLoS ONE. 2015;10:e0140085. doi: 10.1371/journal.pone.0140085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140085</ArticleId><ArticleId IdType="pmc">PMC4599893</ArticleId><ArticleId IdType="pubmed">26452223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekezie W., Awwad S., Krauchenberg A., Karara N., Dembiński Ł., Grossman Z., Del Torso S., Dornbusch H.J., Neves A., Copley S., et al. For The ImmuHubs Consortium. Access to Vaccination among Disadvantaged, Isolated and Difficult-to-Reach Communities in the WHO European Region: A Systematic Review. Vaccines. 2022;10:1038. doi: 10.3390/vaccines10071038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071038</ArticleId><ArticleId IdType="pmc">PMC9324407</ArticleId><ArticleId IdType="pubmed">35891201</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>